ARYx Places $21.6 Million PIPE

ARYx Therapeutics Inc. (Nasdaq: ARYX), a Fremont, Calif.-based developer of retro-metabolic drugs, has placed a $21.6 million IPO. New Enterprise Associates led the placement, and was joined by fellow existing shareholders MPM Capital and OrbiMed Advisors. ARYx had raised over $110 million in VC funding before going public last November.

North AmericaUSBriefs